Product References
Expression of Snail transcription factor in prostatic adenocarcinoma in Egypt: correlation with Maspin protein expression and clinicopathologic variables.
International journal of clinical and experimental pathology
Fawzy AI,Gayyed MF,Elsaghir GA,Elbadry MS
MA5-12383 was used in immunohistochemistry to study the prognostic value of the immunohistochemical expression of Snail and mapsin in Egyptian prostate adenocarcinoma patients
Fri Mar 21 00:00:00 EDT 2014
Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers.
Cancer science
Toyama A,Suzuki A,Shimada T,Aoki C,Aoki Y,Umino Y,Nakamura Y,Aoki D,Sato TA
MA5-12383 was used in immunohistochemistry to use a proteomic approach to identify ANAX4, PSAT1, CRABP1 and SPB5 as biomarkers of specific histological sub-types of ovarian cancers
Sun Apr 01 00:00:00 EDT 2012
A versatile monoclonal antibody specific to human SERPINB5.
Hybridoma (2005)
Teoh SS,Wang H,Risbridger GP,Whisstock JC,Bird PI
MA5-12383 was used in western blot to characterize a novel monoclonal antibody against the serine protease inhibitor mapsin/SERPINB5
Mon Oct 01 00:00:00 EDT 2012
Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
Wu S,Yu L,Cheng Z,Song W,Zhou L,Tao Y
MA5-12383 was used in immunohistochemistry to study the significance of maspin expression in non-small cell lung cancer
Fri Jun 01 00:00:00 EDT 2012
Maspin expression in epithelial skin tumours: an immunohistochemical study.
Journal of cutaneous and aesthetic surgery
Abdou AG,Maraee AH,El-Monaem Shoeib MA,Abo Saida AM
MA5-12383 was used in immunohistochemistry to investigate the changes of maspin levels in cutaneous basal and squamous cell carcinomas
Sun May 01 00:00:00 EDT 2011
Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
Pathology oncology research : POR
Bircan A,Bircan S,Kapucuoglu N,Songur N,Ozturk O,Akkaya A
MA5-12383 was used in immunohistochemistry to compare expression of Maspin, VEGF, and p53 between carcinomas
Wed Dec 01 00:00:00 EST 2010
Maspin expression in renal cell carcinoma and its correlation with clinicopathologic parameters.
Urology
Turunc T,Bal N,Dirim A,Kuzgunbay B,Gul U,Ozkardes H
MA5-12383 was used in immunohistochemistry to study the expression of maspin in renal cell carcinoma and its correlation with clinicopathologic parameters
Wed Sep 01 00:00:00 EDT 2010
Maspin expression in gastrointestinal stromal tumors.
World journal of surgical oncology
Adim SB,Filiz G,Kanat O,Yerci O,Ozguc H,Aytac B
MA5-12383 was used in immunohistochemistry to investigate the distribution of maspin in gastrointestinal stromal tumors
Fri Mar 26 00:00:00 EDT 2010
Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Pathology, research and practice
Bolat F,Gumurdulu D,Erkanli S,Kayaselcuk F,Zeren H,Ali Vardar M,Kuscu E
MA5-12383 was used in immunohistochemistry to study the correlation of maspin expression with with that of VEGFA, VEGFC and VEGFD in human ovarian carcinoma
Thu Aug 21 00:00:00 EDT 2008
Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters.
Pathology, research and practice
Bal N,Kocer NE,Ertorer ME,Canpolat ET,Kayaselcuk F
MA5-12383 was used in immunohistochemistry to examine the prognostic significance of maspin, E-selectin, and P-selectin in papillary thyroid carcinomas
Tue Dec 02 00:00:00 EST 2008
Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy.
Journal of clinical pathology
Mhawech-Fauceglia P,Dulguerov P,Beck A,Bonet M,Allal AS
MA5-12383 was used in immunohistochemistry to study the prognostic value of ezrin, maspin and nm23-H1 in head and neck squamous-cell carcinoma treated with radical radiotherapy
Thu Feb 01 00:00:00 EST 2007
Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.
Journal of clinical pathology
Tsoli E,Tsantoulis PK,Papalambros A,Perunovic B,England D,Rawlands DA,Reynolds GM,Vlachodimitropoulos D,Morgan SL,Spiliopoulou CA,Athanasiou T,Gorgoulis VG
MA5-12383 was used in immunohistochemistry to study the expression of maspin and CXCR4 in breast tumors
Thu Mar 01 00:00:00 EST 2007
Clinicopathological significance of maspin expression in breast cancer.
Journal of Korean medical science
Lee MJ,Suh CH,Li ZH
MA5-12383 was used in immunohistochemistry to study the expression of mapsin in invasive ductal carcinoma of the breast and the correlation with clinicopathological features
Sat Apr 01 00:00:00 EST 2006
Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association
Ito Y,Yoshida H,Tomoda C,Uruno T,Takamura Y,Miya A,Kobayashi K,Matsuzuka F,Matsuura N,Kuma K,Miyauchi A
MA5-12383 was used in immunohistochemistry to study the association of maspin expression with biological aggressiveness of thyroid carcinoma
Thu Jan 01 00:00:00 EST 2004